AbbVie (NYS: ABBV)

AbbVie is a corporation based in North Chicago, Illinois. Established in 2013, the company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy. The company sells the products to wholesalers, distributors, government agencies, healthcare facilities, specialty pharmacies, and independent retailers from distribution centers and public warehouses. The assets of the firm are managed and governed by the board of directors.